Tenderwize
Back to tender search

Open-house rebate contracts for valproic acid (non-retarded form)

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 595 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Valproinsäure in nicht retardierter Darreichungsform, ATC N03AG01

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

62 / 100

Complexity

58 / 100

Risk factors

Paper documents sent to the wrong channel or not received as original duplicate copies by the stated deadline may be in...

Only pharmaceutical companies are eligible, and a signed declaration of reliability is mandatory.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Open-house rebate agreements for the medicinal product valproic acid in non-retarded dosage form, ATC N03AG01.
  • Supply contract for pharmaceutical products.
Show full summary

This is an open-house pharmaceutical supply arrangement by AOK Bayern for valproic acid in non-retarded form (ATC N03AG01), not a competitive award procedure in the usual sense. The buyer intends to conclude identical, non-exclusive contracts with all interested pharmaceutical companies that meet the stated suitability requirement. The contract period runs from 2026-06-01 to 2028-05-31, with contract conclusion possible until 2028-04-03. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German language is required, and non-German documents must be submitted with German translation. No contract value is provided.

Risks

Paper documents sent to the wrong channel or not received as original duplicate copies by the stated deadline may be in...

Only pharmaceutical companies are eligible, and a signed declaration of reliability is mandatory.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability must be submitted.
  • The signed contract and the completed annex 'Determination of the medicinal products covered by the contract' must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate contracts for valproic acid (non-retarded form)

Single lot from structured data. Scope: open-house rebate agreements for pharmaceutical products containing valproic acid in non-retarded dosage form, ATC N03AG01. The arrangement is non-exclusive and identical for all qualifying pharmaceutical companies. Place of performance is Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Deadline

Deadline Apr 03, 2028

Procurement Details

Publication date
14 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
255761-2026

Documents (2)

Similar tenders